Conservative therapies to treat pain and anxiety associated with temporomandibular disorders: a randomized clinical trial
Conservative therapies to treat pain and anxiety associated with temporomandibular disorders: a randomized clinical trial
复制标题
DOI：
10.1111/idj.12546
复制
发表时间：
2020-08-01
影响因子：
3.3
通讯作者：
de Almeida, Erika Oliveira
中科院分区：
文献类型：
--
作者：
Melo, Rafaela Albuquerque;Bastos Machado de Resende, Camila Maria;de Almeida, Erika Oliveira
简介 颞下颌功能障碍 (TMD) 是一种影响口颌系统的疾病。目的 确定咬合夹板 (OS)、手法治疗 (MT)、咨询 (CS) 以及咬合夹板与咨询相结合 (OSCS) 治疗对 TMD 患者疼痛和焦虑的效果。材料和方法 一项随机临床试验对 89 名通过 RDC/TMD（颞下颌疾病研究诊断标准）诊断为 TMD 的患者进行，分为四组治疗：OSCS（n = 25）；OSCS（n = 25）；操作系统 (n = 24)； MT（n = 21）；和 CS (n = 19)。在治疗 1 个月之前和之后对参与者进行疼痛、焦虑和 TMD 诊断评估。通过视觉模拟量表测量疼痛。为了评估焦虑，使用了医院焦虑和抑郁量表（HADS）、贝克焦虑量表（BAI）和状态特质焦虑量表（STAI-S 和 T）。使用SPSS（社会科学统计软件包）22.0对数据进行分析。结果 治疗 1 个月后，四组疼痛显着减轻（P < 0.001）。所有组的治疗均促进完成后 1 个月焦虑症状显着减轻，HADS (P < 0.001)、BAI (P < 0.001)、STAI-T (P = 0.006)。因此，在减少研究变量方面，没有哪一组优于另一组。结论 使用的疗法可有效减轻 TMD 患者的疼痛和焦虑。然而，在减少研究变量方面，没有一种治疗方法优于其他治疗方法。
Introduction Temporomandibular dysfunction (TMD) is a condition that affects the stomatognathic system. Objective To determine the effect of treatment with an occlusal splint (OS), manual therapy (MT), counselling (CS) and the combination of an occlusal splint and counselling (OSCS) on pain and anxiety in patients with TMD. Materials and methods A randomised clinical trial was conducted with 89 patients diagnosed with TMD through RDC/TMD (Research Diagnostic Criteria for Temporomandibular Disorders) and divided into four groups of treatment: OSCS (n = 25); OS (n = 24); MT (n = 21); and CS (n = 19). Participants were assessed before and after 1 month of therapy for pain, anxiety and TMD diagnosis. Pain was measured by a visual analogue scale. To assess anxiety, Hospital Anxiety and Depression Scale (HADS), Beck Anxiety Inventory (BAI) and the State-Trait Anxiety Inventory (STAI-S and T) were used. The data were analysed using SPSS (Statistical Package for Social Science) 22.0. Results The four groups obtained a significant reduction (P < 0.001) in the pain after 1 month of treatment. Treatment in all groups promoted a significant reduction in anxiety symptoms 1 month after completion, HADS (P < 0.001), BAI (P < 0.001), STAI-T (P = 0.006). Thus, no group was superior to the other in reducing the studied variables. Conclusion The therapies used were effective in reducing pain and anxiety in patients diagnosed with TMD. However, no treatment was superior to the other in reducing the studied variables.